# aTyr Pharma (ATYR) — Earnings

ATYR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atyr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.22 |
| EPS estimate | −$0.18 |
| EPS surprise | −19.24% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 7, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1339970/000133997025000009/atyr-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 7, 2025 | −$0.18 | −$0.22 | -19.24% | — | — |
| Q1 2025 | May 7, 2025 | −$0.19 | −$0.17 | 10.99% | — | — |
| Q4 2024 | Mar 13, 2025 | −$0.23 | −$0.18 | 20.21% | $15,556.00 | — |
| Q3 2024 | Nov 7, 2024 | −$0.22 | −$0.23 | -4.55% | $21,667.00 | — |
| Q2 2024 | Aug 13, 2024 | −$0.25 | −$0.23 | 9.20% | $60,000.00 | — |
| Q1 2024 | May 2, 2024 | −$0.25 | −$0.23 | 8.00% | $36,667.00 | $235,000.00 |
| Q4 2023 | Mar 14, 2024 | −$0.24 | −$0.25 | -5.04% | $3.4M | — |
| Q3 2023 | Nov 9, 2023 | −$0.23 | −$0.20 | 11.50% | $1.5M | $353,000.00 |
| Q2 2023 | Aug 9, 2023 | −$0.28 | −$0.22 | 21.03% | $611,667.00 | — |
| Q1 2023 | May 9, 2023 | −$0.35 | −$0.29 | 17.14% | $2.4M | — |
| Q4 2022 | Mar 9, 2023 | −$0.48 | −$0.26 | 45.83% | $357,143.00 | $10.4M |
| Q3 2022 | Nov 10, 2022 | −$0.46 | −$0.46 | 0.71% | $400,000.00 | — |
| Q2 2022 | Aug 15, 2022 | −$0.38 | −$0.44 | -15.18% | $2.5M | — |
| Q1 2022 | May 9, 2022 | −$0.32 | −$0.44 | -39.24% | $200,000.00 | — |
| Q4 2021 | Mar 14, 2022 | −$0.28 | −$0.31 | -9.42% | $2.5M | — |
| Q3 2021 | Nov 12, 2021 | −$0.59 | −$0.42 | 29.16% | $266,667.00 | — |
| Q2 2021 | Aug 11, 2021 | −$0.51 | −$0.64 | -25.98% | $621,800.00 | — |
| Q1 2021 | May 13, 2021 | −$0.32 | −$0.51 | -60.63% | $4.0M | — |
| Q4 2020 | Mar 23, 2021 | −$0.82 | −$0.47 | 42.91% | $126,000.00 | $2.1M |
| Q3 2020 | Nov 12, 2020 | −$0.74 | −$0.68 | 8.52% | $103,333.00 | $148,000.00 |

## Frequently Asked Questions

### When did aTyr Pharma (ATYR) last report earnings?

aTyr Pharma last reported on Aug 7, 2025, covering fiscal Q2 2025.

### Did ATYR beat earnings estimates?

No. aTyr Pharma reported EPS of −$0.22 for Q2 2025 against a −$0.18 estimate — a 19.24% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).